Imagine a world where a single drug could shift the trajectory of blood cancer treatment, offering hope to thousands battling chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). At the recent American Society of Hematology (ASH) meeting in Orlando, Eli Lilly thrust its BTK
Imagine a world where a persistent, hacking cough in a child could be diagnosed as whooping cough in under 20 minutes, right at the doctor’s office, preventing weeks of uncertainty and potential spread. This scenario is now closer to reality with Roche’s latest FDA-cleared point-of-care test for
Imagine a world where living to 100 is common, yet the decline of mind and body feels just as relentless as it does today—where longer life doesn’t mean slower aging. This paradox lies at the heart of a provocative critique by Dr. Dan Ehninger and Dr. Maryam Keshavarz, published in Genomic
What if the key to beating the most common type of breast cancer lay hidden in the body's own defenses, waiting for science to unlock its potential? For the millions of women diagnosed with estrogen receptor-positive (ER-positive) breast cancer, which accounts for about 70% of all cases, a new
What happens when the very architects of public health safety turn against their own system, warning of a dangerous shift that could jeopardize millions of lives? Twelve former FDA commissioners, a powerhouse of regulatory wisdom, have ignited a firestorm by publicly condemning proposed changes to
Diving into the mysteries of the human brain, I’m thrilled to sit down with a leading expert in neuroscience whose groundbreaking work has reshaped our understanding of brain plasticity and adult neurogenesis. As a full professor at the University of Amsterdam and head of the Brain Plasticity
